10-Q: Privia Health Reports Strong Q2 2026 Growth

Privia Health Group, Inc. announced significant revenue increases and improved operating income for the second quarter of 2026, driven by FFS patient care and value-based care initiatives.

Summary

• Privia Health Group, Inc. reported a 21.4% increase in revenue for the three months ended June 30, 2026, reaching $632.6 million, and a 23.5% increase for the six months ended June 30, 2026, totaling $1.24 billion.
• Operating income saw a substantial rise of 252.9% to $11.8 million for the quarter and 124.4% to $19.2 million for the six-month period.
• Net income attributable to Privia Health Group, Inc. increased by 236.7% to $9.0 million for the quarter and 75.4% to $12.1 million for the six months.
• Key non-GAAP metrics also showed improvement, with Adjusted EBITDA increasing by 29.1% for the quarter and 32.6% for the six months.
• The company expanded its operations by acquiring a 77% stake in PMG-NJ in May 2026, entering the New Jersey market.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive report, with strong revenue growth and improved profitability metrics, despite some increases in operating expenses. The company's strategic expansion and value-based care initiatives appear to be driving solid performance.

Positives

• Revenue increased by 21.4% year-over-year for the three months ended June 30, 2026, reaching $632.6 million.
• Revenue for the six months ended June 30, 2026, increased by 23.5% to $1.24 billion.
• Operating income grew significantly by 252.9% to $11.8 million for the quarter.
• Net income attributable to Privia Health Group, Inc. more than tripled to $9.0 million for the quarter.
• Adjusted EBITDA increased by 29.1% to $37.4 million for the quarter, indicating strong operational performance.
• Attributed Lives increased by 19.2% compared to the prior year, a key driver for value-based care revenue.
• The company successfully entered the New Jersey market with the acquisition of PMG-NJ.

Negatives

• Provider expenses increased by 23.3% for the quarter and 24.9% for the six months, largely in line with revenue growth but still a significant cost.
• Cost of platform expenses increased by 6.8% for the quarter and 10.7% for the six months.
• Depreciation and amortization expense increased by 29.9% for the quarter and 48.0% for the six months, primarily due to acquisitions.
• Net cash used in operating activities was $48.4 million for the six months ended June 30, 2026, compared to $16.1 million in the prior year period.

Risks

• The heavily regulated healthcare industry and potential non-compliance with healthcare laws could result in financial penalties or exclusion from government programs.
• Changes in applicable laws, rules, or regulations impacting health plans, payers, and Medicare/Medicaid programs pose a risk.
• Dependence on relationships with Medical Groups, some of which are not wholly owned, presents a risk.
• The growth strategy may not prove viable, and expected results may not be realized.
• Difficulties in implementing the Privia Technology Solution for new Medical Groups could hinder growth.
• High competition in the industry and failure to compete effectively or innovate are ongoing risks.
• Challenges in establishing presence in new geographic markets, acquiring entities, or integrating new markets.
• Reliance on EMR vendor athenahealth, Inc. for the Privia Technology Solution.

Future Outlook

The company expects revenue to grow year-over-year in absolute dollars due to FFS contracts with annual rate inflators and enhanced commercial FFS rates, coupled with an expanding provider base. Investments in sales and marketing, technology, and operations are expected to continue to drive long-term growth, with a focus on moving markets towards value-based care.

Management Comments

• The number of Implemented Providers increased 10.1% as of June 30, 2026 compared to June 30, 2025, due to organic growth and acquisitions.
• Attributed Lives increased 19.2% as of June 30, 2026 compared to June 30, 2025, primarily due to acquisitions and organic growth.
• Practice Collections increased 12.4% for the three months ended June 30, 2026, and 13.4% for the six months ended June 30, 2026, mainly due to organic growth and acquisitions.
• Care Margin increased 14.7% for the three months and 18.3% for the six months, due to organic growth of the medical practice business.
• Platform Contribution Margin was 52.2% for the three months and 52.1% for the six months, showing improvement over the prior year periods.
• Adjusted EBITDA increased by 29.1% for the three months and 32.6% for the six months, due to organic growth, acquisitions, and growth in Attributed Lives.

Industry Context

StockSavvy.ai notes that Privia Health's performance aligns with broader industry trends towards value-based care and physician enablement. The company's growth in FFS and VBC revenue streams, coupled with strategic acquisitions, positions it to capitalize on the ongoing shift in healthcare reimbursement models.

Comparison to Industry Standards

• The company's revenue growth of 21.4% for the quarter and 23.5% for the six months outpaces the general healthcare services sector growth rates.
• The increase in Adjusted EBITDA margin to 28.3% for the quarter and 28.4% for the six months indicates strong operational efficiency, potentially exceeding industry benchmarks for similar physician enablement platforms.
• The 19.2% increase in Attributed Lives suggests effective expansion in value-based care arrangements, a critical area for future healthcare revenue.
• Privia Health's provider retention rate of over 90% is a strong indicator of platform value, likely above industry averages for independent physician groups.
• The company's focus on integrating technology and clinical services to achieve the 'quadruple aim' is a strategic approach that many industry leaders are pursuing.

Legal Proceedings

• The company received a Request for Information from the Department of Health and Human Services Office of Inspector General (OIG) on March 24, 2026, regarding a former affiliated practice's procurement and implantation of medical devices without complying with regulatory requirements. The company is cooperating with the OIG, DOJ, and Virginia Attorney General's office. While not currently believed to be material, the outcome is uncertain.

Related Party Transactions

• A member of the Board of Directors is also a member of the board of trustees of Novant Health, Inc., with whom the company entered into a strategic alignment agreement (Equity Alignment Agreement) on March 2, 2023. No shares have been issued under this agreement as of June 30, 2026.

Stakeholder Impact

• Shareholders: Positive impact from revenue growth, improved profitability, and strategic market expansion.
• Providers: Continued platform value proposition with high retention rates, supporting provider autonomy and financial performance.
• Payers: Potential for improved outcomes and lower costs through value-based care arrangements.
• Patients: Access to a network of providers focused on better outcomes and patient experience.

Next Steps

• Continue to increase provider base in existing and new markets through new practices and recruitment.
• Expand patient panels per provider and drive incremental revenue in both FFS and VBC models.
• Continue to accelerate the move towards adoption of VBC reimbursement in current and emerging payer programs.
• Enhance VBC capabilities and execute initiatives for next-generation access, superior quality metrics, and lower cost of care.
• Continue to leverage the Privia Care Partners model for providers seeking VBC solutions.
• Integrate acquired entities and markets to realize synergies and operational efficiencies.

Key Dates

Recommendation

The company demonstrates strong growth and improving profitability, with strategic expansion into new markets. However, the increasing operating expenses, particularly provider expenses and the ongoing legal inquiry, warrant a cautious approach. While the outlook is positive, further monitoring of expense management and the resolution of the OIG inquiry is advised before considering a more aggressive stance.

Keywords

Privia Health, Physician Enablement, Value-Based Care, Fee-for-Service, Healthcare Technology, Medical Groups, Managed Care, Revenue Growth